[go: up one dir, main page]

AR018825A1 - Antagonistas del receptor de bradiquinina no peptidica para uso en el tratamiento de trastornos y enfermedades oftalmicas - Google Patents

Antagonistas del receptor de bradiquinina no peptidica para uso en el tratamiento de trastornos y enfermedades oftalmicas

Info

Publication number
AR018825A1
AR018825A1 ARP990101487A ARP990101487A AR018825A1 AR 018825 A1 AR018825 A1 AR 018825A1 AR P990101487 A ARP990101487 A AR P990101487A AR P990101487 A ARP990101487 A AR P990101487A AR 018825 A1 AR018825 A1 AR 018825A1
Authority
AR
Argentina
Prior art keywords
treatment
disorders
bradiquinine
antigonists
peptidic
Prior art date
Application number
ARP990101487A
Other languages
English (en)
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of AR018825A1 publication Critical patent/AR018825A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones y uso de una composicion que comprende un antagonista de bradiquina no peptídica para la fabricacion de un medicamento para elojo o para el tratamiento de trastornos o enfermedades oftálmicas, que comprende una composicion que incluye una cantidad terapéuticamente efectivade un antagonista de bradiquinina no peptídica en un vehículo oftálmico farmacéuticamente aceptable. Las composiciones comprenden antagonistas debradiquinina no peptídica.
ARP990101487A 1998-04-03 1999-03-31 Antagonistas del receptor de bradiquinina no peptidica para uso en el tratamiento de trastornos y enfermedades oftalmicas AR018825A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8000398P 1998-04-03 1998-04-03

Publications (1)

Publication Number Publication Date
AR018825A1 true AR018825A1 (es) 2001-12-12

Family

ID=22154279

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990101487A AR018825A1 (es) 1998-04-03 1999-03-31 Antagonistas del receptor de bradiquinina no peptidica para uso en el tratamiento de trastornos y enfermedades oftalmicas

Country Status (4)

Country Link
US (1) US6531480B1 (es)
AR (1) AR018825A1 (es)
AU (1) AU2985499A (es)
WO (1) WO1999051245A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU680870B2 (en) 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
US20070225225A1 (en) * 2006-02-28 2007-09-27 Sharif Najam A Use of natriuretic peptide receptor antagonists to treat ocular, otic and nasal edemetous conditions
US20080160366A1 (en) * 2006-12-29 2008-07-03 Allen Glenn M Porous plate for a fuel cell

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646773B1 (fr) 1989-05-12 1994-05-13 Chauvin Sa Laboratoire Composition pharmaceutique a base de paracetamol
EP0529499A1 (de) * 1991-08-22 1993-03-03 Hoechst Aktiengesellschaft Pharmazeutische Zusammensetzungen enthaltend Bradykinin-Antagonisten zur lokalen Anwendung an Nase und Auge
JPH10316677A (ja) * 1997-05-19 1998-12-02 Fujisawa Pharmaceut Co Ltd 結 晶

Also Published As

Publication number Publication date
WO1999051245A1 (en) 1999-10-14
US6531480B1 (en) 2003-03-11
AU2985499A (en) 1999-10-25

Similar Documents

Publication Publication Date Title
MY127980A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
TW200505402A (en) Ophthalmic drug delivery device
PT1135153E (pt) Utilizacoes para antagonistas e agonistas de receptores eph para tratar desordens vasculares
HUP0103078A2 (hu) Készítmények és eljárások szürkehályog kezelésére
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
MY138394A (en) Combination of mglur2 antagonist and ache inhibitor
SV2002000235A (es) Composiciones farmaceuticas que comprenden valdecoxib
CA2284551A1 (en) New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders
MXPA06002722A (es) Composicion farmaceutica que comprende un antagonista del receptor p2x7 y un farmaco anti-inflamatorio no esteroidal.
ES2174337T3 (es) Uso topico de los agonistas opioides kappa para el tratamiento del dolor ocular.
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
HUP0401805A2 (hu) Pulmonális betegségek kezelésére szolgáló vegyületek
SE9903995D0 (sv) New combination
EE05211B1 (et) Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluh„irete, kohanemish„irete v?i segatpi „rev-depressiivsete h„irete raviks v?i v„ltimiseks kasulike ravimite valmistamiseks
PT1187611E (pt) Composicoes oftalmicas de histamina e sua utilizacoes
PA8552301A1 (es) Metodo para el tratamiento de insomnio primario
AR018825A1 (es) Antagonistas del receptor de bradiquinina no peptidica para uso en el tratamiento de trastornos y enfermedades oftalmicas
EE200100689A (et) IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon
AR018824A1 (es) Antagonistas del receptor de bradiquinina no peptidica para uso en el control de la presion intraocular y en el tratamiento del glaucoma
ES2191908T3 (es) 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido.
DE60014429D1 (de) Zusammensetzungen von adenosin a1 agonisten und 5ht3 agonisten
SE0000303D0 (sv) Novel compounds
ES2181915T3 (es) Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.

Legal Events

Date Code Title Description
FB Suspension of granting procedure